Drug repurposing in the era of COVID-19: a call for leadership and government investment
- PMID: 32372435
- PMCID: PMC7267456
- DOI: 10.5694/mja2.50603
Drug repurposing in the era of COVID-19: a call for leadership and government investment
Keywords: COVID-19; Drug industry; Drugs, generic; Infectious diseases; Medicine, traditional; Policy, drugs and alcohol; Respiratory tract infections; Virology.
Similar articles
-
Repurposing old drugs as antiviral agents for coronaviruses.Biomed J. 2020 Aug;43(4):368-374. doi: 10.1016/j.bj.2020.05.003. Epub 2020 May 23. Biomed J. 2020. PMID: 32563698 Free PMC article.
-
Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.JAMA. 2020 Sep 8;324(10):928. doi: 10.1001/jama.2020.15948. JAMA. 2020. PMID: 32897326 No abstract available.
-
Rapid repurposing of drugs for COVID-19.Science. 2020 May 22;368(6493):829-830. doi: 10.1126/science.abb9332. Epub 2020 May 8. Science. 2020. PMID: 32385101 No abstract available.
-
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.Biochem Soc Trans. 2020 Jun 30;48(3):1287-1295. doi: 10.1042/BST20200505. Biochem Soc Trans. 2020. PMID: 32510142 Review.
-
Clinical Trials of Repurposed Antivirals for SARS-CoV-2.Antimicrob Agents Chemother. 2020 Aug 20;64(9):e01101-20. doi: 10.1128/AAC.01101-20. Print 2020 Aug 20. Antimicrob Agents Chemother. 2020. PMID: 32631826 Free PMC article. Review.
Cited by
-
Buying time: Drug repurposing to treat the host in COVID-19H.Pharmacol Res Perspect. 2020 Aug;8(4):e00620. doi: 10.1002/prp2.620. Pharmacol Res Perspect. 2020. PMID: 32578336 Free PMC article.
-
Application of antimicrobial, potential hazard and mitigation plans.Environ Res. 2022 Dec;215(Pt 1):114218. doi: 10.1016/j.envres.2022.114218. Epub 2022 Aug 29. Environ Res. 2022. PMID: 36049514 Free PMC article. Review.
-
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19.Br J Clin Pharmacol. 2021 Mar;87(3):875-885. doi: 10.1111/bcp.14551. Epub 2020 Nov 18. Br J Clin Pharmacol. 2021. PMID: 32959913 Free PMC article. Review.
-
In-silico drug repurposing study: Amprenavir, enalaprilat, and plerixafor, potential drugs for destabilizing the SARS-CoV-2 S-protein-angiotensin-converting enzyme 2 complex.Results Chem. 2021 Jan;3:100094. doi: 10.1016/j.rechem.2020.100094. Epub 2020 Dec 28. Results Chem. 2021. PMID: 33520633 Free PMC article.
-
Statins in COVID-19: A new ray of hope.Heart Lung. 2020 Nov-Dec;49(6):887-889. doi: 10.1016/j.hrtlng.2020.07.012. Epub 2020 Aug 11. Heart Lung. 2020. PMID: 32861559 Free PMC article. No abstract available.
References
-
- European Medicines Agency . EMA gives advice on the use of non‐steroidal anti‐inflammatories for COVID‐19 [press release]. 18 Mar 2020. https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-ant... (viewed Apr 2020).
-
- National AIDS Treatment Advocacy Project . The coronavirus conundrum: ACE2 and hypertension edition [press release]. 24 Mar 2020. http://natap.org/2020/COVID/032320_16.htm (viewed Apr 2020).
-
- Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotech 2020; 38: 379–381. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous